Navigation Links
Sequenom, Inc. Reports Financial Results For The First Quarter Of 2013
Date:5/9/2013

greater control in monitoring our payments from payors and improved workflows that will help us improve our collection cycle and reimbursement."

Operational Updates
The Company recently reported that Sequenom CMM had processed 100,000 MaterniT21 PLUS samples since launch of the testing service in October 2011, reflecting the overwhelmingly positive response from the physician community based on the superior attributes of the test and customer support offered by Sequenom CMM.  Nearly 60% of maternal-fetal medicine specialists and more than 3,300 OBGYN physicians in the United States have ordered the test since its introduction.  

The annualized run rate for the MaterniT21 PLUS test at the end of the first quarter surpassed 140,000 samples.  This growth has continued with a record number of samples accessioned in the last week of April and Sequenom CMM expects to exceed 150,000 samples accessioned for all of 2013. 

During the first quarter, Sequenom CMM published several key studies that support enhanced performance and clinical utility of both the MaterniT21 PLUS test, and the RetnaGene™ AMD laboratory-developed test for age related macular degeneration (AMD).  A publication in PLOS One in March 2013 describes the basis of process enhancements to the MaterniT21 PLUS test, along with equivalence data in a large clinical sample set.

Sequenom CMM also announced that the MaterniT21 PLUS test now reports on the presence of fetal sex chromosomal aneuploidies, in addition to its identification of aneuploidies for chromosomes 21, 18 and 13. Results of a blinded clinical study reporting on detection of sex aneuploidies have been accepted for publication in Prenatal Diagnosis and is available online.  

A large patient study published in Ophthalmology in March 2013 describes enhancements to the clinical utility of the RetnaGene AMD test by demonstratin
'/>"/>

SOURCE Sequenom, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Morning Research on Sequenom, Peregrine Pharma, Onyx Pharma, and Inovio Pharma
2. Sequenom, Inc. Reports Financial Results For The Fourth Quarter And Full Year Of 2012
3. Sequenom, Inc. Announces Date Of Fourth Quarter And Full Year 2012 Financial Results And Conference Call
4. Sequenom, Inc. Reports Financial Results For The First Quarter Of 2012
5. Nektar Therapeutics Reports Financial Results for the First Quarter of 2013
6. Simcere Pharmaceutical Group Reports Preliminary Unaudited First Quarter 2013 Results
7. Chindex International, Inc. Reports First Quarter 2013 Financial Results
8. BioScrip Reports First Quarter 2013 Financial Results
9. China Biologic Reports Financial Results for the First Quarter of 2013
10. Nephros Reports First Quarter 2013 Financial Results
11. PharmAthene Reports First Quarter 2013 Financial And Operational Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... CUPERTINO, Calif. , March 30, 2015 /PRNewswire/ ... announced that it has initiated a multi-dose Phase ... DUR-928, the lead molecule in DURECT,s Epigenomic Regulator ... entity (NCE) that may have broad applicability in ... (NAFLD) and nonalcoholic steatohepatitis (NASH).  It may also ...
(Date:3/30/2015)... Sorrento Therapeutics, Inc. (Nasdaq: SRNE ) ... to the position of Executive Vice President & ... be responsible for all legal, compliance and intellectual property ... BioDelivery Sciences International, Inc., where he was Senior Vice ... management that led that company to over a six ...
(Date:3/30/2015)... -- Eli Lilly and Company (NYSE: LLY ) ... the investment community and media on the company,s diabetes ... 75th American Diabetes Association® Scientific Sessions, will include multiple ... review of the Phase III data for basal insulin ... The meeting will be held from 7-8:30 ...
Breaking Medicine Technology:DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 2Sorrento Announces Appointment Of George Ng As EVP & Chief Legal Officer 3Lilly Announces Date for Diabetes Investor Meeting 2
... ABBOTT PARK, Ill., Feb. 8 A new diagnostic ... form of ovarian cancer may soon be available in the ... simple blood test to help in monitoring for the recurrence or ... be the first automated HE4 test available in the United ...
... HAYWARD, Calif. , Feb. 8 Anthera ... treat serious diseases associated with inflammation, announced today that it ... (FDA) on a Special Protocol Assessment (SPA) for the Phase ... Acute Coronary Syndrome - 16 Weeks) for its lead product ...
Cached Medicine Technology:Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval 2Abbott Submits New Automated Ovarian Cancer Test for U.S. Approval 3Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors 2Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors 3
(Date:3/30/2015)... Los Angeles, CA (PRWEB) March 30, 2015 ... “6 New Ways to Blast Away Fat,” details six new ... these treatments require injections and one is a topical product. ... ( UltraShape and Liposonix ) or freezing cold ... “There are so many options now available to us to ...
(Date:3/30/2015)... 30, 2015 In a recent report ... Governor Chris Christie is championing effective drug and alcohol ... is scrambling to recover funds to stabilize the addiction ... for victims of drug and alcohol addiction. Harbor Village ... plagued by substance use disorders in New Jersey, in ...
(Date:3/30/2015)... This report studies the global pharmacovigilance and drug ... 2014 to 2019. This market is expected to ... to 2019. , Further Inquiry @ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=16831714 ... and drug safety software market has been classified ... namely, adverse event reporting software, drug safety audits ...
(Date:3/30/2015)... 2015 Dr. Daniel Shapiro, one of the ... recently featured on Phoenix’s Channel 12 News about the benefits ... minimally invasive alternative to facelifts developed by Dr. Shapiro. , ... at Shapiro Aesthetic Plastic Surgery and Skin Klinic worked closely ... news story on GenXLift. The story detailed the experience and ...
(Date:3/30/2015)... GenSight ®, provider of an Enterprise Portfolio Management ... Forrester Wave™: Strategic Planning For The [Business Technology] BT ... GenSight as a leader and gave the company the ... analytics, corporate strategy, assessment, direction and life cycle support ... Leaders category. , According to the report: GenSight ...
Breaking Medicine News(10 mins):Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4Health News:Dr. Daniel Shapiro Unveils New Minimally Invasive Facelift Procedure on Local Newscast 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 3
... never make it big in Hollywood as she feels she is too ... short impedes her. She says: I don't think that's ever going to ... tend to look really small on camera. ,'I can probably ... to be it. I have a feeling I am way too small.' ...
... workers who were abducted by Taliban at gunpoint were ... that they were all health workers. // They abduction ... militants snatched on Thursday a vehicle carrying the 15 ... after their identity was made clear, Outlook newspaper quoted ...
... like angioplasty are the various treatments for people ... is a small industrial city in northeast Ohio. ... the country, would suggest their patients to go ... balloon catheters through arteries and sometimes placing drug-coated ...
... Nepal have irked student organizations who came out on the ... roads and stoned vehicles and burnt tyres on the streets. ... population of Nepal is furious with the price hike, which ... student wings of two of the leading parties in the ...
... reports of moderate iodine deficiency among New Zealanders and ... the Trans-Tasman regulator// Food Standards Australia New Zealand (FSANZ) ... iodized salt in some common household products. Recent ... not getting enough of iodine. ,The proposal by ...
... Scientists have achieved a very important milestone in the mapping ... enhance the health and aid better disease// control in cattle. ... industry immensely. ,Scientists firmed up on a sequence ... the value of the difference even in one pair, which ...
Cached Medicine News:Health News:Heart Procedure numbers go haywire in an Ohio City 2Health News:Fuel Price Hike Triggers Violent Protests In Nepal 2Health News:Fuel Price Hike Triggers Violent Protests In Nepal 3
... is a fully adjustable, air-displacement pipette with ... the latest member of the Pipetman family, ... accuracy, and precision. We also added a ... our customers. Eight models cover the full ...
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
... Seven digital models cover the range from 2ul ... fluently. Volume lock design prevents inadvertent volume ... horizontal grip. Whole pipette is autoclavable at ... is all polypropylene. Suitable for one-handed operation. ...
This adjustable-volume digital micropipet is used to accurately measure and transfer small solution volumes in the 0.5-10 microliter range....
Medicine Products: